Ureidopyridazine derivatives as Acyl-CoA:cholesterol acyltransferase inhibitors

A series of N-(2,4-difluorophenyl)-N’-heptyl-N’-{4-[(substituted)-pyridazin-3-yl)thio]pentyl}urea derivatives having a phenyl ring at positions 5 and/or at position 6 of the heterocycle, as well as the corresponding sulfones, were synthesized. Their inhibitory activity against acyl-CoA:cholesterol acyltransferase (ACAT) was tested on the enzyme prepared from rat liver microsomes. Theoretical studies were performed to correlate their activity to their structural features.

[1]  K. Wasan,et al.  Potential Role of Acyl-Coenzyme A:Cholesterol Transferase (ACAT) Inhibitors as Hypolipidemic and Antiatherosclerosis Drugs , 2005, Pharmaceutical Research.

[2]  A. Gelain.  Pyridazine Derivatives as Novel Acyl‐CoA:Cholesterol Acyltransferase (ACAT) Inhibitors , 2005 .

[3]  J. VandeBerg,et al.  Cholesterol absorption and hepatic acyl-coenzyme A:cholesterol acyltransferase activity play major roles in lipemic response to dietary cholesterol and fat in laboratory opossums. , 2004, Metabolism: clinical and experimental.

[4]  G. Norata,et al.  Lipid lowering activity of drugs affecting cholesterol absorption. , 2004, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  A. Gelain,et al.  Novel 3‐Arylamino‐ and 3‐Cycloalkylamino‐5, 6‐diphenyl‐pyridazines Active as ACAT Inhibitors , 2002, Archiv der Pharmazie.

[6]  A. Gelain,et al.  Mono‐ and Di‐Substituted 5,6‐Diphenyl‐3‐alkylaminopyridazines Active as ACAT Inhibitors. , 2002 .

[7]  A. Gelain,et al.  Mono- and Di-substituted 5,6-Diphenyl-3-alkylaminopyridazines Active as ACAT Inhibitors , 2002 .

[8]  L. Toma,et al.  5,6-Diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors. , 2001, Journal of medicinal chemistry.

[9]  G. Celentano,et al.  5,6-dinitrophenyl and 5-aminophenyl-6-nitrophenyl analogues of the acat inhibitor 5,6-diphenyl-3-alkylaminopyridazines , 2000 .

[10]  R. Anderson,et al.  Acyl-coenzyme A:cholesteryl acyltransferase 2. , 1999, Current opinion in lipidology.

[11]  Catherine C. Y. Chang,et al.  Recombinant Acyl-CoA:cholesterol Acyltransferase-1 (ACAT-1) Purified to Essential Homogeneity Utilizes Cholesterol in Mixed Micelles or in Vesicles in a Highly Cooperative Manner* , 1998, The Journal of Biological Chemistry.

[12]  K. Son,et al.  GERI-BP001 compounds, new inhibitors of acyl-CoA: cholesterol acyltransferase from Aspergillus fumigatus F37. I. Production, isolation, and physico-chemical and biological properties. , 1995, The Journal of antibiotics.

[13]  T. Maduskuie,et al.  Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles. , 1994, Journal of medicinal chemistry.

[14]  A. Mckillop,et al.  One-pot preparation of 6-substituted 3(2H)-pyridazinones from ketones , 1993 .

[15]  C. Wermuth,et al.  Synthesis and Structure‐Activity Relationships of a Series of Aminopyridazine Derivatives of γ‐Aminobutyric Acid Acting as Selective GABA‐A Antagonists. , 1987 .

[16]  C. Wermuth,et al.  Synthesis and structure-activity relationships of a series of aminopyridazine derivatives of gamma-aminobutyric acid acting as selective GABA-A antagonists. , 1987, Journal of medicinal chemistry.